Pcas
Alain de Salaberry is the CEO of the QUANTEL Group, a manufacturer of solid state lasers for industrial and medical applications. QUANTEL is publicly traded on Euronext, has 300 employees including 60 in the US.
Before establishing the QUANTEL Group in 1993, he was managing his own startup company developing home automation products. He had previously held various positions with ALCATEL as well as with the PARIBAS bank. He is a graduate from Ecole Polytechnique in France
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Pcas
Pcas SA, formerly Produits Chimiques Auxiliaires Et De Synthese SA, is a France-based company engaged in the development and manufacture of complex molecules for life sciences and specialty chemicals markets. It operates through nine production sites and two main business units, Pharma Synthesis and Fine & Specialty Chemicals. Pharma Synthesis unit specializes in active pharmaceutical ingredients (API), intermediates and building blocks, and early phase services, among others. Fine & Specialty Chemicals unit focuses on custom manufacturing and proprietary products, such as fragrance, flavor ingredients, imaging and microelectronics chemicals. The Company operates several subsidiaries, including Saint-Jean Photochimie, Societe Bearnaise de Synthese, Expansia, PCAS BioMatrix Inc, based in Canada, and PCAS Finland Oy, based in Finland, among others.